| Type | Public (NYSE:EXEL) |
|---|---|
| Founded | 1994 |
| Headquarters | South San Francisco, California, USA |
| Key people | George Scangos, CEO Michael Morrissey, President, Research and Development Frank Karbe, CFO Gisela M. Schwab, Executive Vice President and Chief Medical Officer Pamela A. Simonton, Executive Vice President and General Counsel Peter Lamb, Senior Vice President, Discovery Research and Chief Scientific Officer Lupe M. Rivera, Senior Vice President, Operations |
| Industry | Biotechnology |
| Website | http://www.exelixis.com/ |
Exelixis is a genomics-based drug discovery company located in South San Francisco, Ca. It works on the development of anti-cancer therapies. Exelixis has several compounds in various stages of FDA approval and is listed on NASDAQ (EXEL).
   | Exelixis - Exelixis-an integrated drug discovery and development company, drug research, discovery and clinical development |
| | EXEL - EXEL` stock quote - Exelixis, Inc. stock price - NASDAQ.com |
|
|
Wikis
Search
